3D hydrogels are three-dimensional cross-linked networks of hydrophilic polymers that can absorb and retain large amounts of water. In recent years, these hydrogels have received widespread attention for their potential applications in tissue engineering, drug delivery, and biomedical research. These cross-linked polymer hydrogels can replicate the extracellular matrix found in nature.
In the context of the blood-brain barrier (BBB), 3D hydrogels can be used to create 3D models of the BBB in vitro. Researchers can recreate the complex structure and physiology of the BBB in a laboratory setting by using 3D hydrogels as a substrate. Additionally, these hydrogels can be functionalized with specific molecules to mimic the biochemical and biophysical properties of the blood-brain barrier. In Transwell models, for example, researchers can culture traditionally immortalized cells embedded in hydrogels to form multicellular complexes called spheroids. Furthermore, stem cells grown in 3D hydrogels can differentiate into multiple cell types that closely resemble native tissues, such as human iPSC-derived brain microvascular endothelial cells, that can be programmed to form 3D organoid BBB models, which are ideal, reproducible, and scalable in vitro models of the BBB.
The advantage of using 3D hydrogels as BBB model substrates is that they provide a more realistic representation of brain tissue compared to traditional 2D cell culture systems. Furthermore, 3D hydrogel models can form multicellular layers and establish cell-cell interactions, which are crucial for studying the barrier function of the BBB.
Naturally Derived 3D Hydrogels | Synthetic 3D Hydrogels |
Biologically derived natural ECM extracts are the most commonly used 3D hydrogels to simulate physiological extracellular matrix in vitro. Currently, ECM extracts of Engelbreth-Holm-Swarm (EHS) murine sarcoma basement membrane have been widely used in 3D cell culture. | Synthetic 3D hydrogels are matrices for cell culture achieved through cross-linked polymer networks. Chemically defined hydrogel formulations enhance reproducibility compared to native 3D hydrogels, and the presence and concentration of culture medium components (e.g., growth factors) are known. |
Ace Therapeutics provides a variety of naturally derived 3D hydrogels and synthetic 3D hydrogel kits to help you construct an ideal, stable 3D BBB model in vitro that meets your research needs.
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-117 | 3D Organoid Hydrogel |
3D Organoid Hydrogel is a ready-to-use hydrogel system for the three-dimensional (3D) rganoid culture. The product without xeno-free (no animal origin) supports the growth of patient-derived organoids or organoids developed from pluripotent stem cells (PSC), co-culture, and PDX models.
|
inquiry |
BBM-3C-118 | 3D Stem Hydrogel |
3D Stem Hydrogel is a ready-to-use hydrogel system for the three-dimensional (3D) mesenchymal stem cells culture. It is animal-free and can be used directly with cells for 3D culture or to generate hydrogel cell beads.
|
inquiry |
BBM-3C-119 | 3D MSC Hydrogel Kit |
3D MSC Hydrogel Kit is a ready-to-use hydrogel system for the three-dimensional (3D) mesenchymal stem cells (MSC) culture. It is animal-free and can be used directly with cells for 3D culture or to generate hydrogel cell beads.
|
inquiry |
BBM-3C-120 | 3D Hydrogel Kit (Native) |
3D Hydrogel Kit (Native), a natural, animal-free, ready-to-use hydrogel, creates a 3D cell culture environment that mimics the extracellular matrix (ECM) to support cell growth and differentiation.
|
inquiry |
BBM-3C-121 | 3D Cell Culture Hydrogel (PNIPAAm-PEG) |
3D Cell Culture Hydrogel (PNIPAAm-PEG) from Ace Therapeutics is a highly lipophilic, temperature-reversible polymer gel. This product transforms into a gel at higher temperatures (37°C) while remaining liquid at lower temperatures (4°C). This product is used for 3D cell culture, tissue engineering, and drug delivery.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.